Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SDGRthis companySchrödinger, Inc.	$32.74	-12.68×	3.61×	5.13×	-12.38×	-212.0%	55.7%	-65.2%	-40.4%	-28.4%	-30.2%	0.9%	0.3×	1.26×	0×	2.75×	0.0%	3	2.98	1	C-
CERTCertara, Inc.	$12.39	-881×	1.33×	3.37×	12.05×	-35.2%	61.5%	5.0%	-0.4%	-0.2%	-0.3%	4.9%	0.01×	-1.74×	1.06×	2.05×	0.0%	7	2.6	2	C+
GENBGenerate Biomedicines, Inc.	$13.88	-2.54×	-1.03×	19.87×	-2.78×	-546.2%	100.0%	-737.0%	-637.0%	33.0%	-89.4%	-32.2%	-0.11×	0.25×	-206.92×	2.85×	0.0%	—	—	1	C-
HYFTMindWalk Holdings Corp.	$1.10	-5.39×	6.39×	4.89×	-5.11×	-295.2%	58.8%	-96.0%	-89.7%	-117.1%	-89.2%	-16.9%	0.3×	0.59×	0×	2.8×	0.0%	3	-9.88	1	D+
LTRNLantern Pharma Inc.	$0.57	-1.93×	5.05×	0×	-6.26×	-1222.3%	0.0%	0.0%	0.0%	-262.0%	-21.1%	-47.5%	12.02×	-4.33×	0×	2.4×	0.0%	1	-22.94	2	C+
RLAYRelay Therapeutics, Inc.	$19.93	-5.25×	2.56×	94.54×	-5.13×	-104.1%	76.8%	-1971.6%	-1800.6%	-48.8%	-50.5%	-16.2%	0.06×	0.19×	0×	22.61×	0.0%	3	26.32	2	C
Peer median	—	-5.25×	2.56×	4.89×	-5.11×	-295.2%	61.5%	-96.0%	-89.7%	-48.8%	-50.5%	-16.9%	0.06×	0.19×	0×	2.8×	0.0%	3	-3.64	2	—